<DOC>
	<DOCNO>NCT01769950</DOCNO>
	<brief_summary>Nodal involvement among patient prostate cancer know poor prognostic factor . Traditionally , presence absence nodal disease patient prostate cancer ascertain use anatomical image method compute tomography ( CT ) magnetic resonance imaging ( MRI ) . However , sensitivity CT MRI detection pelvic nodal disease rather low , report place value lie 50-80 % . Positron emission tomography ( PET ) use carbon-11 fluorine-18 tag choline ( Choline-PET ) approach know deliver high sensitivity image prostate cancer disease burden primary , nodal metastatic area . The investigator prospective trial intend utilize Choline-PET among newly diagnose patient prostate cancer presume non-N1 ( absence nodal disease conventional imaging ) non-M1 ( absence metastatic disease conventional imaging ) .</brief_summary>
	<brief_title>Choline-PET Evaluating Incidence Nodal Metastases Among Newly Diagnosed Patients Prostate Cancer</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Choline</mesh_term>
	<criteria>Consenting patient Diagnosed prostate cancer Metastatic disease presentation</criteria>
	<gender>Male</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Choline PET</keyword>
	<keyword>Choline PET-CT</keyword>
	<keyword>Positron emission tomography</keyword>
	<keyword>Prostate cancer</keyword>
</DOC>